3 ms·
Yes, just in the US, and only one of the sets of patents in the US. This one is about use of CRISPR-Cas9 in a eukaryotic environment specifically. Both parties
by riemannzeta 5y ago
Yes, just in the US, and only one of the sets of patents in the US. This one is about use of CRISPR-Cas9 in a eukaryotic environment specifically. Both parties have some other claims, and ultimately will have to cross-license each other for the technology to develop. Too bad such an important decision is being left to such a small group of university administrators who know very little about how best to grow the technology into successful therapies and technologies at scale!